What is the CTOR stock price prediction for next 2 weeks?

According to our price prediction algorithm,Citius Oncology, Inc. (CTOR) price will be around $1.01 in the next 2 weeks. This means it will increase by 11.82522123893804 from the last closing price. This prediction may vary from other time period filters for CTOR stock.

What can be the highest Possible price of CTOR stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CTOR can achieve the highest price of $1.11 which is 22.70805038068854 higher than last closing price. This prediction may vary from other time period filters for CTOR stock.

What can be the lowest Possible price of CTOR stock in next 2 weeks?

As per the forecast and algorithmic analysis, CTOR stock price can be as low as $0.92 which is 1.522332832433495 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for CTOR stock.

Will CTOR stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that CTOR stock will gain11.82522123893804 in the next 2 weeks. This prediction may vary from other time period filters for CTOR stock.

What is CTOR stock last closing price?

Last closing price of CTOR stock was $0.90.

What is CTOR stock price prediction?

CTOR stock price prediction means predicting the future closing prices of CTOR stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CTOR stock in a certain time period.

How we predict CTOR stock future prices?

If you are searching for CTOR stock forecast, analysis or price prediction, then you might be wondering what Citius Oncology, Inc. (CTOR) will do in the future. Our CTOR price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CTOR price prediction will likely answer most of your questions.

How frequent we update CTOR stock predictions?

We are updating the forecasts for the CTOR stock on daily basis.

Is using ML forecasting for CTOR stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CTOR stock same for all the time periods?

No, the prediction for CTOR stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Citius Oncology, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.904.28%Since 2 Weeks

Predicted Price$1.0111.83%For 2 Weeks

Upper Predicted Price$1.1122.71%For 2 Weeks

Lower Predicted Price$0.921.52%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CTOR will rise by +11.83% over the next 2 Weeks and hit $1.01 by Monday, May 25, 2026. In that time frame, CTOR's share price is expected to range between $0.92 and $1.11.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 25, 2026	0.92	1.01	1.11
May 22, 2026	0.90	1.00	1.09
May 21, 2026	0.94	1.03	1.14
May 20, 2026	0.91	1.00	1.09
May 19, 2026	0.91	1.01	1.10
May 18, 2026	0.87	0.96	1.06
May 15, 2026	0.86	0.95	1.04
May 14, 2026	0.88	0.98	1.07
May 13, 2026	0.85	0.95	1.05
May 12, 2026	0.86	0.96	1.05

CTOR shares rose +0.09% in Tuesday, May 12, 2026's trading session, rising from a previous close of $0.90 to move at $0.90. The stock demonstrated notable intraday movement (see CTOR's key stats for a full breakdown), fluctuating between $0.85 and $0.91, a +7.45% trading range. While recent weeks have seen some volatility, CTOR has managed to secure a +3.58% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 283.5K shares changing hands, 230.69K more than the previous session. This amounted to $256.51K in total market activity.

Will CTOR Continue Its Upward Trend?

According to analyst ratings and projections for CTOR, Citius Oncology, Inc. shares are anticipated to increase by +18.43%, potentially reaching $1.11 per share by May 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for CTOR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the CTOR stock forecast, now is a good time to buy CTOR stock because its current trading price is -10.50% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CTOR covering social and institutional perspectives.

CTOR Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CTOR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.41% to 55.25%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.79%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.18%, maintains a neutral outlook for the long term. Insights into CTOR's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Citius Oncology Short-Term Forecasts

CTOR Forecast For Next 5 Days

Our algorithm anticipates Citius Oncology (CTOR) stock could hit $0.84 by May 19, 2026. This represents a -7.66% fall from today's price, following a -1.87% change over the past five days.

CTOR Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Citius Oncology, Inc. (CTOR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.81, which would mean a -10.48% decrease from the current price of $0.90. Projections for this period range from a high of $1.18 to a low of $0.42.

CTOR Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Citius Oncology's price over the next three months point to a rise. CTOR stock is expected to peak at $2.69 on Jun 29, 2026 before potentially dipping to $0.22 on Aug 07, 2026. On average, CTOR is likely to trade around $1.28 in the coming 90 days.

Citius Oncology Stock Forecast 2025

Based on our predictive models, Citius Oncology (CTOR) is expected to trade between $0.00 and $2.69 throughout 2026. This would result in an average price of $0.82, potentially offering investors a -9.37% return from current levels.

Citius Oncology, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Citius Oncology, Inc. (CTOR) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.74 and $2.15, settling at an average of $1.37. This could translate to a +51.41% gain.

June 2026

Based on current market signals, Citius Oncology, Inc. is projected to trend june 2026. We forecast a trading range from $0.27 to $2.69, with a likely average price of $1.40. Investors could expect a potential return of +54.73%.

July 2026

Our predictive algorithms indicate Citius Oncology, Inc. stock may see a shift in July 2026. The expected range spans $0.32–$2.39, with an average target of $1.27. This represents a positive outlook and a possible gain of +40.36%.

August 2026

Analyzing established trends, Citius Oncology, Inc. looks set to move in August 2026. Projections place the stock between $0.00 and $1.51, averaging around $0.75. This suggests a -17.11% loss from current levels.

September 2026

Market indicators suggest Citius Oncology, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $1.04, with a midpoint forecast of $0.43. The stock might deliver a -52.48% loss.

October 2026

Forecasting for October 2026, models estimate that Citius Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.95, averaging $0.51. This signals a cautious trajectory with potential returns around -43.63%.

November 2026

According to our latest forecast models, Citius Oncology, Inc. (CTOR) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $0.69, settling at an average of $0.51. This could translate to a -43.63% loss.

December 2026

Based on current market signals, Citius Oncology, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $0.39, with a likely average price of $0.47. Investors could expect a potential return of -48.05%.

January 2027

Our predictive algorithms indicate Citius Oncology, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$0.00, with an average target of $0.37. This represents a cautious outlook and a possible loss of -59.11%.

February 2027

Analyzing established trends, Citius Oncology, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $0.00, averaging around $0.27. This suggests a -70.16% loss from current levels.

March 2027

Market indicators suggest Citius Oncology, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.22. The stock might deliver a -75.69% loss.

April 2027

Forecasting for April 2027, models estimate that Citius Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.18. This signals a cautious trajectory with potential returns around -80.11%.

May 2027

According to our latest forecast models, Citius Oncology, Inc. (CTOR) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.17. This could translate to a -81.21% loss.

CTOR's history of dividends and stock splits also plays a role in long-term investor confidence.